Cytos Biotechnology AG

We are a Swiss-headquartered global innovation company with 150 years’ combined research experience in the field of biologics for spinal fusion. Our commercial & research footprint spans three continents and covers more than 10 markets. 

We believe that a greater quality and quantity of science holds the key to easing the burden of spine surgery – especially as high non-union rates force surgeons, medical organizations and insurers to reassess the bone grafts they choose. Our response? Project Fusion: a global research program that brings together an unprecedented blend of scientific, pre-clinical and clinical studies.